ArticlemAbs2016

A comparison of anti-HER2 IgA and IgG1 in vivo efficacy is facilitated by high N-glycan sialylation of the IgA.

Gerard Ja Rouwendal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.